New antiarrhythmic agents in pediatrics.
This article reviews recent developments in the pharmacologic management of arrhythmias in children and provides specific information about six newer antiarrhythmic agents. With the current increase in recognition, frequency, and complexity of rhythm disturbances in children, pediatricians can expect to encounter children on these antiarrhythmic medications in their practices with increasing frequency.
Case
C L
CL
South Carolina Children's Heart Center, Charleston.
Trippel
D L
DL
Gillette
P C
PC
D000200:Action Potentials / Q000187:drug effects; D000638:Amiodarone / Q000494:pharmacology; D000813:Anilides / Q000494:pharmacology; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D001262:Atenolol / Q000494:pharmacology; D002648:Child; D002675:Child, Preschool; D016700:Encainide; D005424:Flecainide / Q000494:pharmacology; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D007223:Infant; D010372:Pediatrics
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D001262:Atenolol; D005424:Flecainide; D000638:Amiodarone; D016700:Encainide